Report ID :10352227 |
Published Date : 01 Nov 2022 |
Report Format : |
Delivery Timeline :48-72 Business Hours
Global Cell Therapy Technologies Market Highlights Over 2020 - 2030
The global cell therapy technologies market is estimated to garner a revenue of USD 45754.6 Million by the end of 2030, by growing at a CAGR of 13.6% over the forecast period, i.e., 2021 – 2030. Moreover, in the year 2020, the market generated a revenue of USD 12902.1 Million. The growth of the market can primarily be attributed to the growing incidences of chronic and infectious diseases worldwide, especially amongst the elderly population, and the growing utilization of cell therapy technologies for the treatment of these chronic and infectious diseases. Cellular therapy is the process of replacement or repair of damaged tissues and cells. In other words, it deals with the transplantation of human cells by using different advanced technologies. The market is also anticipated to grow on account of the growing elderly population worldwide, as this age group is highly prone to get infected by chronic diseases. According to the statistics by the World Bank, the population aged 65 and above as a share of the total population, increased from 6.874% in the year 2000 to 9.318% in the year 2020.
GET A SAMPLE COPY OF THIS REPORT
Besides this, the increasing number of research and clinical trials that are undergoing in the field of oncology-related cellular therapy, along with the surge in need for newer, better therapies for diseases such as cancer and cardiovascular diseases (CVDs), are also expected to drive the market growth in the coming years. Moreover, the rise in focus on precision medicine, along with the increasing advancements registered in the field of cell-based immunotherapies, such as CAR-T therapy, are also expected to generate numerous opportunities for market growth in the coming years.
Global Cell Therapy Technologies Market Regional Synopsis
Regionally, the global cell therapy technologies market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa region. The market in North America region is anticipated to garner the largest revenue of USD 19957.2 Million by the end of 2030, up from a revenue of USD 5848.5 Million in the year 2020. The growth of the market in the region can primarily be attributed to the increasing growing incidences of chronic diseases in the region, and therefore the rising need for advanced medications developed from cell therapy technologies. According to the statistics by the United States Centers for Disease Control and Prevention (CDC), out of 10 adults, 6 adults have been registered to have a chronic disease in the United States. The market in the region is also anticipated to grow on account of the availability of a strong medical infrastructure in the region and the increasing research activities undergone by several healthcare organizations in the region for the development of advanced cell therapy technologies.
On the other hand, the market in Europe is expected to garner the second-largest revenue of USD 12448.8 Million by the end of 2030, up from a revenue of USD 3380.4 Million in the year 2020. The market in the region is further segmented by country into Germany, United Kingdom, France, Italy, Spain, Russia, Netherlands, and the Rest of Europe. Out of these, the market in Germany is expected to garner the largest revenue of USD 2405.8 Million by the end of 2030, up from a revenue of USD 618.6 Million in the year 2020.
Growth Drivers and Challenges Impacting the Growth of the Global Cell Therapy Technologies Market
Growth Drivers
-
Increasing Incidences of Chronic and Infectious Diseases
-
Rising Research and Clinical Trials in the Field of Cellular Therapy
Challenges
-
High Cost of the Vaccine or Drug Developed from Cell Therapy Technologies
Global Cell Therapy Technologies Market Segmentation Synopsis
The global cell therapy technologies market is segmented by product into consumables, system & software, and equipment. Out of these, the consumables segment is anticipated to garner the largest revenue of USD 17892.6 Million by the end of 2030, up from a revenue of USD 5163.6 Million in the year 2020. Based on process, the market is segmented into process monitoring & quality control, cell processing, cell preservation, distribution, & handling. Out of these, the cell processing segment is anticipated to garner the largest revenue of USD 20663.3 Million by the end of 2030, up from a revenue of USD 5967.0 Million in the year 2020. On the basis of cell type, the market is segmented into T-cells, stem cells, and other cells. Out of these, the T-cells segment is anticipated to garner the largest revenue of USD 18846.2 Million by the end of 2030, up from a revenue of USD 5389.5 Million in the year 2020. The market is also segmented on the basis of end-user into contract research organizations (CROs), biopharmaceuticals & biotech companies, cell banks, research institutes, and other end-users. Out of these, the biopharmaceuticals & biotech companies’ segment is anticipated to generate the largest revenue of USD 16510.1 Million by the end of 2030, up from a revenue of USD 4605.8 Million in the year 2020.
Key Companies Dominating the Market
Our report has covered detailed company profiling comprising company overview, business strategies, key product offerings, financial performance, key performance indicators, risk analysis, recent developments, regional presence, and SWOT analysis among other notable indicators for competitive positioning. Some of the prominent industry leaders in the global cell therapy technologies market that are included in our report are Lonza Group Ltd., Sartorius AG, Danaher Corporation, Becton, Dickinson and Company, Thermo Fisher Scientific Inc., Avantor, Inc., Eppendorf SE, Miltenyi Biotec B.V. & Co. KG, and others.
Latest Developments in the Global Cell Therapy Technologies Market
-
October 28th, 2021: Avantor, Inc. announced that it has opened a new single-use facility in Hillegom, Netherlands. This newly added facility will add significant value to the overall cleanroom capacity of the company in the European region.
-
September 27th, 2021: Sartorius AG announced that by late 2023, it would be opening a new 130,000 sq. ft state-of-the-art plant in Ann Arbor, Michigan, United States.
Key Reasons to Buy Our Report
-
The report covers a detailed analysis comprising market share attained by each market segment and its sub-segments.
-
It covers market dynamics including growth drivers, trends, potential opportunities, price trend analysis, and challenges that impact market growth.
-
The report includes detailed company profiles of the major players dominating the market.
-
We use effective research methodologies to calculate the market numbers and provide value-added assessments for overall growth.
-
We provide customized reports as per the clients’ requirement helping them to see possible and unexpected challenges and unforeseen opportunities in order to help them reach their goal.
1. Introduction
1.1. Market Definition
1.2.Market Segmentation
2. Assumptions
3. Research Methodology
3.1.Research Process
3.2. Primary Research
3.3. Secondary Research
4. Executive Summary – Global Cell Therapy Technologies Market
5. Market Dynamics
5.1. Market Drivers
5.2. Market Trends
6. Key Market Opportunities
7. Major Roadblocks for the Market Growth
8. Regulatory and Standards Landscape
9. Industry Risk Analysis
10. Pricing Analysis of Cell therapy Technologies Market
11. Value Chain Analysis
12.Impact of COVID-19 on the Cell Therapy Technologies Market
13.Market Share Analysis Based on Therapy
14.Competitive Positioning
15. Competitive Landscape
15.1. Market Share Analysis, 2020
15.2. Competitive Benchmarking
15.3. Company Profiles
15.3.1. Lonza Group Ltd.
15.3.2. Sartorius AG
15.3.3. Danaher Corporation
15.3.4. Becton
15.3.5. Dickinson and Company
15.3.6. Thermo Fisher Scientific Inc.
15.3.7. Avantor, Inc.
15.3.8. Eppendorf SE
15.3.9. Miltenyi Biotec B.V. & Co. KG
16.KOL Mapping
17. Bioreactors Market Analysis w.r.t. Product, Region, and Year
18.Future Forecast of the Manufactures and Startup Companies
19.Global Cell Therapy Technologies Market 2020-2030
19.1. Market Overview
19.2. By Value (USD Million)
20. Global Cell Therapy Technologies Market – Segmentation analysis 2020-2030
20.1. Product
20.1.1. Consumables, 2020-2030F (USD Million)
20.1.2. System & Software, 2020-2030F (USD Million)
20.1.3. Equipment, 2020-2030F (USD Million)
20.1.3.1. Cell Processing Equipment, 2020-2030F (USD Million)
20.1.3.2. Single-Use Equipment, 2020-2030F (USD Million)
20.1.3.3. Other Cell Therapy Equipment, 2020-2030F (USD Million)
20.2. Process
20.2.1. Process Monitoring and Quality Control, 2020-2030F (USD Million)
20.2.2. Cell Processing, 2020-2030F (USD Million)
20.2.3. Cell Preservation, distribution and Handling, 2020-2030F (USD Million)
20.3. Cell Type
20.3.1. T-Cells, 2020-2030F (USD Million)
20.3.2. Stem Cells, 2020-2030F (USD Million)
20.3.3. Other Cells, 2020-2030F (USD Million)
20.4. End-User
20.4.1. Contract Research Organizations (CROs), 2020-2030F (USD Million)
20.4.2. Biopharmaceuticals & Biotech Companies, 2020-2030F (USD Million)
20.4.3. Cell banks, 2020-2030F (USD Million)
20.4.4. Research institutes, 2020-2030F (USD Million)
20.4.5. Other End-Users, 2020-2030F (USD Million)
20.5. Region
20.5.1. North America, 2020-2030F (USD Million)
20.5.2. Europe, 2020-2030F (USD Million)
20.5.3. Asia Pacific, 2020-2030F (USD Million)
20.5.4. Latin America, 2020-2030F (USD Million)
20.5.5. Middle East & Africa, 2020-2030F (USD Million)
21.North America Therapy Technologies Market – Segmentation analysis 2020-2030
21.1. Product
21.1.1. Consumables, 2020-2030F (USD Million)
21.1.2. System & Software, 2020-2030F (USD Million)
21.1.3. Equipment, 2020-2030F (USD Million)
21.1.3.1. Cell Processing Equipment, 2020-2030F (USD Million)
21.1.3.2. Single-Use Equipment, 2020-2030F (USD Million)
21.1.3.3. Other Cell Therapy Equipment, 2020-2030F (USD Million)
21.2. Process
21.2.1. Process Monitoring and Quality Control, 2020-2030F (USD Million)
21.2.2. Cell Processing, 2020-2030F (USD Million)
21.2.3. Cell Preservation, distribution and Handling, 2020-2030F (USD Million)
21.3. Cell Type
21.3.1. T-Cells, 2020-2030F (USD Million)
21.3.2. Stem Cells, 2020-2030F (USD Million)
21.3.3. Other Cells, 2020-2030F (USD Million)
21.4. End-User
21.4.1. Contract Research Organizations (CROs), 2020-2030F (USD Million)
21.4.2. Biopharmaceuticals & Biotech Companies, 2020-2030F (USD Million)
21.4.3. Cell banks, 2020-2030F (USD Million)
21.4.4. Research institutes, 2020-2030F (USD Million)
21.4.5. Other End-Users, 2020-2030F (USD Million)
21.5. Country
21.5.1. United States, 2020-2030F (USD Million)
21.5.2. Canada, 2020-2030F (USD Million)
22. Europe Therapy Technologies Market – Segmentation analysis 2020-2030
22.1. Product
22.2. Process
22.3. Cell-Type
22.4. End-User
22.5. Country
22.5.1. Germany
22.5.2. United Kingdom
22.5.3. France
22.5.4. Italy
22.5.5. Spain
22.5.6. Russia
22.5.7. Netherland
22.5.8. Rest of Europe
23. Asia Pacific Technologies Market – Segmentation analysis 2020-2030
23.1. Product
23.2. Process
23.3. Cell-Type
23.4. End-User
23.5. Country
23.5.1. China
23.5.2. India
23.5.3. Japan
23.5.4. South Korea
23.5.5. Australia
23.5.6. Singapore
23.5.7. Rest of APAC
24. Latin America Technologies Market – Segmentation analysis 2020-2030
24.1. Product
24.2. Process
24.3. Cell-Type
24.4. End-User
24.5. Country
24.5.1. Brazil
24.5.2. Argentina
24.5.3. Mexico
24.5.4. Rest of LATAM
25. Middle East & Africa Technologies Market – Segmentation analysis 2020-2030
25.1. Product
25.2. Process
25.3. Cell-Type
25.4. End-User
25.5. Country
25.5.1. GCC
25.5.2. Israel
25.5.3. South Africa
25.5.4. Rest of MEA
Frequently Asked Question
The market is segmented by product, process, cell type, end-user, and by region.
The consumables segment is anticipated to garner the largest revenue of USD 17892.6 Million by the end of 2030 and display significant growth opportunities.
Why Choose Kenneth Research ?
-
Insight with Impact : We don’t just gather data — we uncover stories, trends, and opportunities that fuel business growth.
-
Experts Who Get It : Our team speaks your industry’s language and knows what really matters to your customers and market.
-
Custom-Built for You : Forget one-size-fits-all. We craft research and consulting solutions as unique as your business vision.
-
Partners, Not Just Providers : We work with you, not for you — collaborating closely to turn insights into smart, strategic moves.
-
Results That Speak : Our work powers brands, startups, and industry leaders alike — with a track record of ideas that work in the real world.
